The cancer stem cell: Cell type or cell state?

Cytometry Part A

Volumn 83 A, Issue 1, 2013, Pages 5-7

  Donnenberg, Albert D ^a,b,c   Hicks, James B ^d   Wigler, Michael ^d   Donnenberg, Vera S ^a,b,c  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Howard Hughes Medical Institute Cold Spring Harbor Laboratory Cold Spring Harbor   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CANCER STEM CELL; CELL CYCLE; CELL DIFFERENTIATION; CELL TRANSFORMATION; EDITORIAL; GENE EXPRESSION REGULATION; HUMAN; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; CELL CYCLE; CELL DIFFERENTIATION; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS;

EID: 84871648070     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22208     Document Type: Editorial

References (15)

1. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, Yamanaka S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-872.
2. Mikkers H, Frisen J. Deconstructing stemness. The EMBO J 2005; 24: 2715-2719.
3. Casanova J. Stemness as a cell default state. EMBO Rep 2012; 13: 396-397.
4. Zipori D. The stem state: Mesenchymal plasticity as a paradigm. Current Stem Cell Res Therapy 2006; 1: 95-102.
5. Sell S. Cellular origin of cancer: Dedifferentiation or stem cell maturation arrest? Environ Health Perspect 1993; 101 (Suppl 5): 15-26.
6. Spike BT, Wahl GM. p53, stem cells, and reprogramming. Genes Cancer 2011; 2: 404-419.
7. Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, et al. Tumour evolution inferred by single-cell sequencing. Nature 2011; 472: 90-94.
8. Kim M-Y, Oskarsson T, Acharyya S, Nguyen DX, Zhang XHF, Norton L, Massagué J. Tumor self-seeding by circulating cancer cells. Cell 2009; 139: 1315-1326.
9. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature 2001; 414: 105-111.
10. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-3988.
11. Fabian A, Barok M, Vereb G, Szollosi J. Die hard: Are cancer stem cells the Bruce Willises of tumor biology? Cytometry A 2009; 75A: 67-74.
12. Donnenberg VS, Landreneau RJ, Donnenberg AD. Tumorigenic stem and progenitor cells: Implications for the therapeutic index of anti-cancer agents. J Control Release 2007; 122: 385-391.
13. Zimmerlin L, Donnenberg AD, Rubin JP, Basse P, Landreneau RJ, Donnenberg VS. Regenerative therapy and cancer: In vitro and in vivo studies of the interaction between adipose-derived stem cells and breast cancer cells from clinical isolates. Tissue Eng Part A 2011; 17: 93-106.
14. Donnenberg VS, Donnenberg AD, Zimmerlin L, Landreneau RJ, Bhargava R, Wetzel RA, Basse P, Brufsky AM. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors. Cytometry B Clin Cytom 2010; 78B: 287-301.
15. Donnenberg VS, Luketich JD, Landreneau RJ, DeLoia JA, Basse P, Donnenberg AD. Tumorigenic epithelial stem cells and their normal counterparts. Ernst Schering Foundation Symp Proc 2006; 5: 245-263.